India is rapidly establishing itself as a global hub for neutraceutical active pharmaceutical ingredient development, driven NEUTRACEUTICAL SUPPLIER MEDIOCON by a combination of factors including competitive costs, a skilled workforce, and supportive government policies. Numerous companies are now focusing on the synthesis and distribution of these